CD8A and neoplasm: A recent study using the polyoma virus middle T oncoprotein (PyMT) murine model of breast cancer found that IL-38 inhibition resulted in reduced tumour burden along with an increase in the activation and tumour infiltration of CD8+ T cells and γδ T cells.